GRIA2 and glioblastoma: This synaptic interaction modulates GBM cell development and proliferation, as seen with genetic inhibition (dominant‐negative GluA2 subunit expression of AMPA in GBM cells) or by pharmacological AMPA receptors suppression in GBM‐neuron coculture and in vivo.7